We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+7.42%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$14.1B
AUM Growth
+$2.17B
(+18%)
Cap. Flow
+$1.47B
Cap. Flow
% of AUM
10.47%
Top 10 Holdings %
Top 10 Hldgs %
18.97%
Holding
1,309
New
346
Increased
287
Reduced
265
Closed
392
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$177M |
| 2 |
Lowe's Companies
LOW
|
+$108M |
| 3 |
STJ
St Jude Medical
STJ
|
+$95.4M |
| 4 |
Newell Brands
NWL
|
+$88.6M |
| 5 |
Constellation Brands
STZ
|
+$87.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EMC
EMC CORPORATION
EMC
|
+$136M |
| 2 |
UnitedHealth
UNH
|
+$99.3M |
| 3 |
PayPal
PYPL
|
+$85.4M |
| 4 |
Starbucks
SBUX
|
+$78.1M |
| 5 |
Cigna
CI
|
+$64.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.63% |
| 2 | Consumer Discretionary | 12.48% |
| 3 | Communication Services | 12.09% |
| 4 | Technology | 9.72% |
| 5 | Industrials | 9.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
SEI Investments
SEIC
$11.9B
| $10.4M | 0.07% |
+227,622
| New | +$10.7M |
|
277
Nektar Therapeutics
NKTR
$2.39B
| $10.3M | 0.07% |
39,880
+24,001
| +151% | +$6.18M |
|
278
Itaú Unibanco
ITUB
$91.3B
| $10.3M | 0.07% |
+2,126,890
| New | +$10.1M |
|
279
Travelers Companies
TRV
$80.8B
| $10.2M | 0.07% |
89,158
-171,140
| -66% | -$20M |
|
280
DuPont de Nemours
DD
$18.6B
| $10.1M | 0.07% |
76,993
+27,945
| +57% | +$3.73M |
|
|
CALD
281
DELISTED
Callidus Software, Inc.
CALD
| $10.1M | 0.07% |
549,720
+266,430
| +94% | +$5.21M |
|
282
Flex
FLEX
$43.4B
| $10.1M | 0.07% |
980,924
+705,980
| +257% | +$6.85M |
|
283
Honeywell
HON
$77.1B
| $10.1M | 0.07% |
95,996
+89,403
| +1,356% | +$9.34M |
|
284
Valvoline
VVV
$4.97B
| $10M | 0.07% |
+426,417
| New | +$10.1M |
|
285
Kinross Gold
KGC
$28.5B
| $9.85M | 0.07% |
2,339,569
+44,818
| +2% | +$216K |
|
|
CAFD
286
DELISTED
8point3 Energy Partners LP
CAFD
| $9.84M | 0.07% |
+683,324
| New | +$10.8M |
|
287
Paylocity
PCTY
$6.71B
| $9.81M | 0.07% |
220,759
+53,436
| +32% | +$2.37M |
|
|
TWX
288
DELISTED
Time Warner Inc
TWX
| $9.79M | 0.07% |
123,045
-15,095
| -11% | -$1.18M |
|
289
VeriSign
VRSN
$25.3B
| $9.76M | 0.07% |
124,779
+67,249
| +117% | +$5.39M |
|
290
PVH
PVH
$3.71B
| $9.7M | 0.07% |
87,750
-53,126
| -38% | -$5.49M |
|
291
Global Payments
GPN
$22.1B
| $9.58M | 0.07% |
124,850
+106,057
| +564% | +$7.99M |
|
|
HRC
292
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $9.58M | 0.07% |
154,604
-128,391
| -45% | -$7.23M |
|
|
SPR
293
DELISTED
Spirit AeroSystems
SPR
| $9.55M | 0.07% |
214,357
-1,264,280
| -86% | -$55.9M |
|
|
EGN
294
DELISTED
Energen
EGN
| $9.53M | 0.07% |
+165,165
| New | +$8.62M |
|
295
Icon
ICLR
$12.8B
| $9.44M | 0.07% |
121,975
+14,056
| +13% | +$1.06M |
|
296
Macerich
MAC
$7.32B
| $9.4M | 0.07% |
116,246
-26,467
| -19% | -$2.24M |
|
|
CYBR
297
DELISTED
CyberArk
CYBR
| $9.38M | 0.07% |
189,330
-254,237
| -57% | -$13.5M |
|
298
Lumentum
LITE
$59.4B
| $9.38M | 0.07% |
224,673
-813,322
| -78% | -$26.8M |
|
|
JNPR
299
DELISTED
Juniper Networks
JNPR
| $9.31M | 0.07% |
387,027
+227,475
| +143% | +$5.27M |
|
300
Tractor Supply
TSCO
$16.3B
| $9.3M | 0.07% |
+690,695
| New | +$11.5M |
|
Similar funds
Marshall Wace's Q3 2016 Portfolio in Review
As of Q3 2016, Marshall Wace held 1,309 positions worth $14.1B, up 18% from $11.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Marshall Wace deployed $1.47B of net new capital in Q3 2016, opening 346 new positions and adding to 287 existing holdings. Its largest new stake was St Jude Medical: 1,181,595 shares worth $94.2M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was UnitedHealth, an estimated $99.3M trimmed.
- Marshall Wace's largest Q3 2016 buy was St Jude Medical: 1,181,595 shares worth $94.2M.
- Marshall Wace added most to Zoetis in Q3 2016, an estimated $177M increase.
- Marshall Wace's biggest Q3 2016 reduction was UnitedHealth, cutting an estimated $99.3M.
- Marshall Wace fully exited EMC CORPORATION in Q3 2016, selling an estimated $136M.
- Marshall Wace's ten largest holdings make up 19% of its $14.1B portfolio in Q3 2016.
- Marshall Wace opened 346 new positions and closed 392 in Q3 2016.
- Marshall Wace's portfolio value rose 18% quarter-over-quarter to $14.1B.
Based on Marshall Wace's 13F filing for Q3 2016, filed 10 Nov 2016.